Logo image of EQVA.OL

EQVA ASA (EQVA.OL) Stock Fundamental Analysis

OSL:EQVA - Euronext Oslo - NO0010708605 - Common Stock - Currency: NOK

4.95  +0.1 (+2.06%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to EQVA. EQVA was compared to 107 industry peers in the Machinery industry. EQVA has an average financial health and profitability rating. EQVA is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

EQVA had positive earnings in the past year.
EQVA had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: EQVA reported negative net income in multiple years.
In multiple years EQVA reported negative operating cash flow during the last 5 years.
EQVA.OL Yearly Net Income VS EBIT VS OCF VS FCFEQVA.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

EQVA has a better Return On Assets (7.32%) than 84.11% of its industry peers.
With an excellent Return On Equity value of 19.11%, EQVA belongs to the best of the industry, outperforming 85.05% of the companies in the same industry.
With an excellent Return On Invested Capital value of 21.66%, EQVA belongs to the best of the industry, outperforming 94.39% of the companies in the same industry.
Industry RankSector Rank
ROA 7.32%
ROE 19.11%
ROIC 21.66%
ROA(3y)-0.99%
ROA(5y)14.41%
ROE(3y)-1.95%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EQVA.OL Yearly ROA, ROE, ROICEQVA.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200

1.3 Margins

Looking at the Profit Margin, with a value of 3.81%, EQVA is in line with its industry, outperforming 48.60% of the companies in the same industry.
EQVA's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 7.08%, EQVA is in line with its industry, outperforming 53.27% of the companies in the same industry.
EQVA's Operating Margin has declined in the last couple of years.
The Gross Margin of EQVA (51.26%) is better than 66.36% of its industry peers.
EQVA's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 7.08%
PM (TTM) 3.81%
GM 51.26%
OM growth 3Y-6.53%
OM growth 5YN/A
PM growth 3Y-58.16%
PM growth 5YN/A
GM growth 3Y19.37%
GM growth 5Y25.52%
EQVA.OL Yearly Profit, Operating, Gross MarginsEQVA.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), EQVA is creating value.
The number of shares outstanding for EQVA has been increased compared to 1 year ago.
EQVA has more shares outstanding than it did 5 years ago.
The debt/assets ratio for EQVA has been reduced compared to a year ago.
EQVA.OL Yearly Shares OutstandingEQVA.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
EQVA.OL Yearly Total Debt VS Total AssetsEQVA.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

EQVA has an Altman-Z score of 3.01. This indicates that EQVA is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 3.01, EQVA is doing good in the industry, outperforming 70.09% of the companies in the same industry.
EQVA has a debt to FCF ratio of 1.90. This is a very positive value and a sign of high solvency as it would only need 1.90 years to pay back of all of its debts.
The Debt to FCF ratio of EQVA (1.90) is better than 81.31% of its industry peers.
A Debt/Equity ratio of 0.35 indicates that EQVA is not too dependend on debt financing.
EQVA has a Debt to Equity ratio (0.35) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 1.9
Altman-Z 3.01
ROIC/WACC2.43
WACC8.93%
EQVA.OL Yearly LT Debt VS Equity VS FCFEQVA.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

2.3 Liquidity

A Current Ratio of 0.98 indicates that EQVA may have some problems paying its short term obligations.
EQVA has a Current ratio of 0.98. This is amonst the worse of the industry: EQVA underperforms 88.78% of its industry peers.
EQVA has a Quick Ratio of 0.98. This is a bad value and indicates that EQVA is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of EQVA (0.93) is worse than 60.75% of its industry peers.
Industry RankSector Rank
Current Ratio 0.98
Quick Ratio 0.93
EQVA.OL Yearly Current Assets VS Current LiabilitesEQVA.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 824.75% over the past year.
The earnings per share for EQVA have been decreasing by -69.46% on average. This is quite bad
The Revenue has grown by 48.40% in the past year. This is a very strong growth!
EQVA shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -13.86% yearly.
EPS 1Y (TTM)824.75%
EPS 3Y-69.46%
EPS 5YN/A
EPS Q2Q%-2.04%
Revenue 1Y (TTM)48.4%
Revenue growth 3Y5.52%
Revenue growth 5Y-13.86%
Sales Q2Q%-1.72%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EQVA.OL Yearly Revenue VS EstimatesEQVA.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 5.69, the valuation of EQVA can be described as very cheap.
EQVA's Price/Earnings ratio is rather cheap when compared to the industry. EQVA is cheaper than 96.26% of the companies in the same industry.
EQVA's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.41.
Industry RankSector Rank
PE 5.69
Fwd PE N/A
EQVA.OL Price Earnings VS Forward Price EarningsEQVA.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

85.05% of the companies in the same industry are more expensive than EQVA, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, EQVA is valued cheaper than 98.13% of the companies in the same industry.
Industry RankSector Rank
P/FCF 3.81
EV/EBITDA 3.99
EQVA.OL Per share dataEQVA.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

EQVA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

EQVA ASA

OSL:EQVA (7/11/2025, 7:00:00 PM)

4.95

+0.1 (+2.06%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.44%
Inst Owner ChangeN/A
Ins Owners1.66%
Ins Owner ChangeN/A
Market Cap405.70M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.2
Dividend Growth(5Y)N/A
DP23.72%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 5.69
Fwd PE N/A
P/S 0.25
P/FCF 3.81
P/OCF 3.48
P/B 1.28
P/tB 49.02
EV/EBITDA 3.99
EPS(TTM)0.87
EY17.58%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.3
FCFY26.23%
OCF(TTM)1.42
OCFY28.73%
SpS19.42
BVpS3.88
TBVpS0.1
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.32%
ROE 19.11%
ROCE 25.24%
ROIC 21.66%
ROICexc 27.86%
ROICexgc 257.21%
OM 7.08%
PM (TTM) 3.81%
GM 51.26%
FCFM 6.69%
ROA(3y)-0.99%
ROA(5y)14.41%
ROE(3y)-1.95%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y43.23%
ROICexcg growth 5YN/A
ROICexc growth 3Y-31.72%
ROICexc growth 5YN/A
OM growth 3Y-6.53%
OM growth 5YN/A
PM growth 3Y-58.16%
PM growth 5YN/A
GM growth 3Y19.37%
GM growth 5Y25.52%
F-Score6
Asset Turnover1.92
Health
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 1.9
Debt/EBITDA 0.86
Cap/Depr 67.63%
Cap/Sales 0.64%
Interest Coverage 5.71
Cash Conversion 91.31%
Profit Quality 175.32%
Current Ratio 0.98
Quick Ratio 0.93
Altman-Z 3.01
F-Score6
WACC8.93%
ROIC/WACC2.43
Cap/Depr(3y)46.03%
Cap/Depr(5y)117.5%
Cap/Sales(3y)0.84%
Cap/Sales(5y)1.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)824.75%
EPS 3Y-69.46%
EPS 5YN/A
EPS Q2Q%-2.04%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)48.4%
Revenue growth 3Y5.52%
Revenue growth 5Y-13.86%
Sales Q2Q%-1.72%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y900.06%
EBIT growth 3Y-1.37%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y287.99%
FCF growth 3Y-30.53%
FCF growth 5YN/A
OCF growth 1Y328.57%
OCF growth 3Y-30.04%
OCF growth 5YN/A